Qizhong Yi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qizhong Yi has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
Xiao Luo
Xinjiang Clinical Medical Research Center of Mental Health, The Psychological Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
5 shared publicationsQiyu Jia
Department of Trauma Orthopaedics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
4 shared publicationsShijie Jiang
Department of Medical Psychology, the first Affiliated Hospital of Xinjiang Medical University, Xinjiang Clinical Research Center for Mental Health, Urumqi, China
4 shared publicationsZhiguo An
Xinjiang Clinical Medical Research Center of Mental Health, The Psychological Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China
4 shared publicationsJunxiong Mao
Xinjiang Clinical Medical Research Center of Mental Health, The Psychological Medicine Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
3 shared publicationsLili Zhang
The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People’s Republic of China
3 shared publications
Latest Publications
- 9 September 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 393 (Pt A) , 120310
Profiles of parental bonding and childhood trauma in a clinical sample: Implications for coping strategies in adulthood among Chinese young adults
- 9 September 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 393 (Pt A) , 120310
Profiles of parental bonding and childhood trauma in a clinical sample: Implications for coping strategies in adulthood among Chinese young adults
- Open Access
- 28 February 2025
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-16
Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia?
This study evaluated the potential of artificial intelligence (AI) in the diagnosis, treatment, and prognostic assessment of schizophrenia (SZ) and explored collaborative directions for AI applications in future medical innovations. SZ is a severe mental disorder that causes significant suffering and imposes challenges on patients. With the rapid advancement of machine learning and deep learning technologies, AI has demonstrated notable advantages in the early diagnosis of high-risk populations. By integrating multidimensional biomarkers and linguistic behavior data of patients, AI can provide further objective and precise diagnostic criteria. Moreover, it aids in formulating personalized treatment plans, enhancing therapeutic outcomes, and offering new therapeutic strategies for patients with treatment-resistant SZ. Furthermore, AI excels in developing individualized prognostic plans, which enables the rapid identification of disease progression, accurate prediction of disease trajectory, and timely adjustment of treatment strategies, thereby improving prognosis and facilitating recovery. Despite the immense potential of AI in SZ management, its role as an auxiliary tool must be emphasized, with clinical judgment and compassionate care from healthcare professionals remaining crucial. Future research should focus on optimizing human–machine interactions to achieve efficient AI application in SZ management. The in-depth integration of AI technology into clinical practice will advance the field of SZ, ultimately improving the quality of life and treatment outcomes of patients.
- 28 February 2025
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-16
Open AccessCan artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia?
This study evaluated the potential of artificial intelligence (AI) in the diagnosis, treatment, and prognostic assessment of schizophrenia (SZ) and explored collaborative directions for AI applications in future medical innovations. SZ is a severe mental disorder that causes significant suffering and imposes challenges on patients. With the rapid advancement of machine learning and deep learning technologies, AI has demonstrated notable advantages in the early diagnosis of high-risk populations. By integrating multidimensional biomarkers and linguistic behavior data of patients, AI can provide further objective and precise diagnostic criteria. Moreover, it aids in formulating personalized treatment plans, enhancing therapeutic outcomes, and offering new therapeutic strategies for patients with treatment-resistant SZ. Furthermore, AI excels in developing individualized prognostic plans, which enables the rapid identification of disease progression, accurate prediction of disease trajectory, and timely adjustment of treatment strategies, thereby improving prognosis and facilitating recovery. Despite the immense potential of AI in SZ management, its role as an auxiliary tool must be emphasized, with clinical judgment and compassionate care from healthcare professionals remaining crucial. Future research should focus on optimizing human–machine interactions to achieve efficient AI application in SZ management. The in-depth integration of AI technology into clinical practice will advance the field of SZ, ultimately improving the quality of life and treatment outcomes of patients.
- Open Access
- 14 January 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1439727
Neurotransmitters crosstalk and regulation in the reward circuit of subjects with behavioral addiction
Behavioral addictive disorders (BADs) have become a significant societal challenge over time. The central feature of BADs is the loss of control over engaging in and continuing behaviors, even when facing negative consequences. The neurobiological underpinnings of BADs primarily involve impairments in the reward circuitry, encompassing the ventral tegmental area, nucleus accumbens in the ventral striatum, and prefrontal cortex. These brain regions form networks that communicate through neurotransmitter signaling, leading to neurobiological changes in individuals with behavioral addictions. While dopamine has long been associated with the reward process, recent research highlights the role of other key neurotransmitters like serotonin, glutamate, and endorphins in BADs’ development. These neurotransmitters interact within the reward circuitry, creating potential targets for therapeutic intervention. This improved understanding of neurotransmitter systems provides a foundation for developing targeted treatments and helps clinicians select personalized therapeutic approaches.
- 14 January 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1439727
Open AccessNeurotransmitters crosstalk and regulation in the reward circuit of subjects with behavioral addiction
Behavioral addictive disorders (BADs) have become a significant societal challenge over time. The central feature of BADs is the loss of control over engaging in and continuing behaviors, even when facing negative consequences. The neurobiological underpinnings of BADs primarily involve impairments in the reward circuitry, encompassing the ventral tegmental area, nucleus accumbens in the ventral striatum, and prefrontal cortex. These brain regions form networks that communicate through neurotransmitter signaling, leading to neurobiological changes in individuals with behavioral addictions. While dopamine has long been associated with the reward process, recent research highlights the role of other key neurotransmitters like serotonin, glutamate, and endorphins in BADs’ development. These neurotransmitters interact within the reward circuitry, creating potential targets for therapeutic intervention. This improved understanding of neurotransmitter systems provides a foundation for developing targeted treatments and helps clinicians select personalized therapeutic approaches.
- Top Cited PapersOpen Access
- 11 January 2025
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-12
The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation
Oxidative stress (OS) is crucial in schizophrenia (SCZ) pathology. Ferroptosis, a recently discovered cell death pathway linked to OS, might contribute to the development of SCZ. This study investigated the association between ferroptosis markers and cognitive impairments in chronic SCZ patients. A retrospective analysis was conducted on 204 chronic SCZ patients with cognitive deficits and 216 healthy controls (HC) matched for relevant characteristics. Plasma levels of ferroptosis and OS markers, including iron, ferritin (FE), transferrin (TF), glutathione peroxidase 4 (GPX4), long-chain acyl-CoA synthetase 4 (ACSL4), glutathione (GSH), sirtuin 1 (SIRT1), nuclear factor erythroid 2-related factor 2 (Nrf2), malondialdehyde (MDA), and superoxide dismutase (SOD) were measured. Standardized assessments like the positive and negative syndrome scale (PANSS), and Montreal Cognitive Assessment (MoCA) were used to evaluate psychiatric symptoms, and cognitive function. SCZ patients showed significant differences in markers compared to the HC group (P < 0.01). Multiple linear regression analysis revealed that decreased GSH and iron levels, along with elevated SOD levels, were significantly associated with the overall severity of psychiatric symptoms. Additionally, reduced GPX4 levels and increased ACSL4 and FE levels were significantly linked to negative symptoms and cognitive impairments. Notably, GPX4 emerged as a key predictor for cognitive function in abstraction and language domains. Our study revealed alterations in the altered plasma levels of GPX4, GSH, iron, ACSL4, FE, and SOD in chronic SCZ patients, which might indicate a close association between biomarkers of ferroptosis and OS and the psychiatric symptoms and cognitive deficits observed in these individuals.
- 11 January 2025
- Published by Springer Nature in Schizophrenia
- Vol. 11 (1) , 1-12
Top Cited PapersOpen AccessThe role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation
Oxidative stress (OS) is crucial in schizophrenia (SCZ) pathology. Ferroptosis, a recently discovered cell death pathway linked to OS, might contribute to the development of SCZ. This study investigated the association between ferroptosis markers and cognitive impairments in chronic SCZ patients. A retrospective analysis was conducted on 204 chronic SCZ patients with cognitive deficits and 216 healthy controls (HC) matched for relevant characteristics. Plasma levels of ferroptosis and OS markers, including iron, ferritin (FE), transferrin (TF), glutathione peroxidase 4 (GPX4), long-chain acyl-CoA synthetase 4 (ACSL4), glutathione (GSH), sirtuin 1 (SIRT1), nuclear factor erythroid 2-related factor 2 (Nrf2), malondialdehyde (MDA), and superoxide dismutase (SOD) were measured. Standardized assessments like the positive and negative syndrome scale (PANSS), and Montreal Cognitive Assessment (MoCA) were used to evaluate psychiatric symptoms, and cognitive function. SCZ patients showed significant differences in markers compared to the HC group (P < 0.01). Multiple linear regression analysis revealed that decreased GSH and iron levels, along with elevated SOD levels, were significantly associated with the overall severity of psychiatric symptoms. Additionally, reduced GPX4 levels and increased ACSL4 and FE levels were significantly linked to negative symptoms and cognitive impairments. Notably, GPX4 emerged as a key predictor for cognitive function in abstraction and language domains. Our study revealed alterations in the altered plasma levels of GPX4, GSH, iron, ACSL4, FE, and SOD in chronic SCZ patients, which might indicate a close association between biomarkers of ferroptosis and OS and the psychiatric symptoms and cognitive deficits observed in these individuals.
- Open Access
- 1 December 2024
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 2443-2455
Does Academic Burnout Alleviate or Exacerbate Internet Dependence in University Students with Depression and Anxiety?
Purpose: This study aims to investigate whether academic burnout alleviates or exacerbates internet dependence among college students with depression and anxiety. Moreover, it intends to construct a moderated mediation model to examine how academic burnout moderates the relationship between depressive and anxious emotions and internet addiction and how social support mediates this relationship to determine the psychological motivations underlying addiction. Methods: A questionnaire survey was conducted using the simple random sampling method, which yielded 757 valid responses (response rate: a 93.11% response rate). The sample included 274 males and 466 females, with an average age of 20.90 years (+/- 1.48). Hierarchical regression analysis was employed for data analysis. Results: Anxiety and depressive symptoms directly affect the internet dependence of university students and indirectly affect it through the mediating role of social support. Academic burnout moderates the relationship between negative emotions and internet addiction, with high levels of academic burnout potentially decreasing the internet dependence of students experiencing negative emotions. We proposed a psychological self-regulation mechanism theory, which posits that learned helplessness may intensify the emotional symptoms of anxiety and depression, which is reflected in reduced internet use behavior. Conclusion: High levels of academic burnout can exacerbate symptoms of depression and anxiety, significantly reducing students' interest in activities. For these students, a decrease in internet addiction may not be a positive sign; instead, it could indicate worsened depression and anxiety. This finding underscores the need for close monitoring of and intervention implementation for college students experiencing high levels of burnout and symptoms of depression or anxiety.
- 1 December 2024
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 2443-2455
Open AccessDoes Academic Burnout Alleviate or Exacerbate Internet Dependence in University Students with Depression and Anxiety?
Purpose: This study aims to investigate whether academic burnout alleviates or exacerbates internet dependence among college students with depression and anxiety. Moreover, it intends to construct a moderated mediation model to examine how academic burnout moderates the relationship between depressive and anxious emotions and internet addiction and how social support mediates this relationship to determine the psychological motivations underlying addiction. Methods: A questionnaire survey was conducted using the simple random sampling method, which yielded 757 valid responses (response rate: a 93.11% response rate). The sample included 274 males and 466 females, with an average age of 20.90 years (+/- 1.48). Hierarchical regression analysis was employed for data analysis. Results: Anxiety and depressive symptoms directly affect the internet dependence of university students and indirectly affect it through the mediating role of social support. Academic burnout moderates the relationship between negative emotions and internet addiction, with high levels of academic burnout potentially decreasing the internet dependence of students experiencing negative emotions. We proposed a psychological self-regulation mechanism theory, which posits that learned helplessness may intensify the emotional symptoms of anxiety and depression, which is reflected in reduced internet use behavior. Conclusion: High levels of academic burnout can exacerbate symptoms of depression and anxiety, significantly reducing students' interest in activities. For these students, a decrease in internet addiction may not be a positive sign; instead, it could indicate worsened depression and anxiety. This finding underscores the need for close monitoring of and intervention implementation for college students experiencing high levels of burnout and symptoms of depression or anxiety.
- Open Access
- 25 October 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (43) , e39710
Schizophrenia and magnetic resonance imaging research: A scientometric analysis during 2014 to 2023
Background: Recently, magnetic resonance imaging (MRI) has emerged as a leading technique for investigating schizophrenia (SZ) pathological mechanisms, prompting an increase in related studies. This study aims to examine the field’s research status and trends via bibliometric analysis. Method: The publications on SZ and MRI over the past decade were retrieved from the Web of Science Core Collection (WOSCC) On October 15, 2023. CiteSpace and VOSviewer were used to conduct scientometric and visualized analysis, covering countries, institutions, authors, journals, co-cited literature, and keywords. Results: A total of 4840 publications were retrieved from 2014 to 2023. The United States leads with 1863 articles, followed by China with 1127 articles. King’s College London had the highest number of publications, with 332 articles. Schizophrenia Research ranks first in the journal that published the research on schizophrenia and MRI, the most published journal, Neuroimage is the most cited journal. Calhoun is the most prolific author with 145 articles, and Fischl is the most cited author, receiving 1188 citations. The literature co-citation network (2014 to 2023) revealed 16 clusters with robust structure (Q = 0.8719) and high confidence (S = 0.9421) involving MRI studies of SZ, genetic imaging and treatment of schizophrenia. Keywords include MRI, psychosis and functional magnetic resonance imaging (fMRI), MRI and neuroimaging, MRI and neuroimaging and white matter and diffusion tensor imaging. Conclusion: This study offers an overview of the research status and trends of publications on SZ and MRI, aiming to inspire future research directions.
- 25 October 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (43) , e39710
Open AccessSchizophrenia and magnetic resonance imaging research: A scientometric analysis during 2014 to 2023
Background: Recently, magnetic resonance imaging (MRI) has emerged as a leading technique for investigating schizophrenia (SZ) pathological mechanisms, prompting an increase in related studies. This study aims to examine the field’s research status and trends via bibliometric analysis. Method: The publications on SZ and MRI over the past decade were retrieved from the Web of Science Core Collection (WOSCC) On October 15, 2023. CiteSpace and VOSviewer were used to conduct scientometric and visualized analysis, covering countries, institutions, authors, journals, co-cited literature, and keywords. Results: A total of 4840 publications were retrieved from 2014 to 2023. The United States leads with 1863 articles, followed by China with 1127 articles. King’s College London had the highest number of publications, with 332 articles. Schizophrenia Research ranks first in the journal that published the research on schizophrenia and MRI, the most published journal, Neuroimage is the most cited journal. Calhoun is the most prolific author with 145 articles, and Fischl is the most cited author, receiving 1188 citations. The literature co-citation network (2014 to 2023) revealed 16 clusters with robust structure (Q = 0.8719) and high confidence (S = 0.9421) involving MRI studies of SZ, genetic imaging and treatment of schizophrenia. Keywords include MRI, psychosis and functional magnetic resonance imaging (fMRI), MRI and neuroimaging, MRI and neuroimaging and white matter and diffusion tensor imaging. Conclusion: This study offers an overview of the research status and trends of publications on SZ and MRI, aiming to inspire future research directions.
- Open Access
- 1 May 2024
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 1011-1024
An Effect of Chronic Negative Stress on Hippocampal Structures and Functional Connectivity in Patients with Depressive Disorder
Purpose: Depressive disorder is a mental health disorder with complicated etiopathogenesis. Environmental stress and neurodevelopment combined with other factors contribute to the occurrence of depression. Especially for the depressive disorder with chronic negative stress, it has characteristics of recurrence and poor curative effect because of unclear mechanism. Here, we investigated the hippocampal structures and functional connectivity (FC) according to resting-state functional magnetic resonance imaging in patients with depression who underwent chronic negative stress. Patients and Methods: A total of 65 patients with depression (34 underwent chronic negative stress and 31 non-underwent chronic negative stress) and 30 healthy controls who did not undergo chronic negative stress were included in the study. The volumes of hippocampal subfields, seed-based FCs between hippocampus and the whole brain voxels, and ROI-wise-based FC between hippocampal subfields were compared among the three groups. Results: In the patients with depression who underwent chronic negative stress, the volumes of right_GC-ML-DG-head, right_CA4-head and right_CA3-head increased, FCs between Temporal_Mid_R, Precuneus_R, Frontal_Sup_R, Temporal_Sup_R, Angular_L, Frontal_Inf_Tri_R, Supp_Motor_Area_R, Precentral_L and hippocampus increased, and FCs between parasubiculum and CA3, and presubiculum and CA1 decreased. When compared to the patients who did not undergo chronic negative stress, the patients who underwent chronic negative stress had larger volumes of right_GC-ML-DG-head and right_CA3-head, higher FCs between Frontal_Sup_R, Frontal_Inf_Tri_R and hippocampus, and lower FCs between presubiculum and CA1. Conclusion: The depression underwent chronic negative stress may experience disrupted hippocampal structures and functional connectivity. It may be one of potential depressive disorder subtypes.
- 1 May 2024
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 1011-1024
Open AccessAn Effect of Chronic Negative Stress on Hippocampal Structures and Functional Connectivity in Patients with Depressive Disorder
Purpose: Depressive disorder is a mental health disorder with complicated etiopathogenesis. Environmental stress and neurodevelopment combined with other factors contribute to the occurrence of depression. Especially for the depressive disorder with chronic negative stress, it has characteristics of recurrence and poor curative effect because of unclear mechanism. Here, we investigated the hippocampal structures and functional connectivity (FC) according to resting-state functional magnetic resonance imaging in patients with depression who underwent chronic negative stress. Patients and Methods: A total of 65 patients with depression (34 underwent chronic negative stress and 31 non-underwent chronic negative stress) and 30 healthy controls who did not undergo chronic negative stress were included in the study. The volumes of hippocampal subfields, seed-based FCs between hippocampus and the whole brain voxels, and ROI-wise-based FC between hippocampal subfields were compared among the three groups. Results: In the patients with depression who underwent chronic negative stress, the volumes of right_GC-ML-DG-head, right_CA4-head and right_CA3-head increased, FCs between Temporal_Mid_R, Precuneus_R, Frontal_Sup_R, Temporal_Sup_R, Angular_L, Frontal_Inf_Tri_R, Supp_Motor_Area_R, Precentral_L and hippocampus increased, and FCs between parasubiculum and CA3, and presubiculum and CA1 decreased. When compared to the patients who did not undergo chronic negative stress, the patients who underwent chronic negative stress had larger volumes of right_GC-ML-DG-head and right_CA3-head, higher FCs between Frontal_Sup_R, Frontal_Inf_Tri_R and hippocampus, and lower FCs between presubiculum and CA1. Conclusion: The depression underwent chronic negative stress may experience disrupted hippocampal structures and functional connectivity. It may be one of potential depressive disorder subtypes.
- Open Access
- 16 October 2023
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 14, 1238254
Profile and mental health characterization of childhood overprotection/overcontrol experiences among Chinese university students: a nationwide survey
Introduction: The childhood experiences of being overprotected and overcontrolled by family members have been suggested to be potentially traumatic. However, the possible associated factors of these experiences among young people are still not well studied. This study aimed to partly fill such gaps by a relatively large, nationwide survey of Chinese university students.Methods: A total of 5,823 university students across nine different provinces in China were included by the convenience sampling method in the data analyses. All participants completed the overprotection/overcontrol (OP/OC) subscale in a recently developed 33-item childhood trauma questionnaire (CTQ- 33). Data were also collected on all participants’ socio-demographic profiles and characterization of mental health. Binary logistic regression was conducted to investigate the associated socio-demographic and psychological factors of OP/ OC.Results: The prevalence of childhood OP/OC was estimated as 15.63% (910/5,823) based on a cutoff OP/OC subscale score of ≥ 13. Binary logistic regression suggested that being male, being a single child, having depression, having psychotic-like experiences, lower family functioning, and lower psychological resilience were independently associated with childhood OP/OC experiences (all corrected-p < 0.05). The OP/OC was also positively associated with all the other trauma subtypes (abuses and neglects) in the CTQ-33, while there are both shared and unique associated factors between the OP/OC and other trauma subtypes. Post-hoc analyses suggested that OP/OC experiences were associated with depression in only females and associated with anxiety in only males.Discussion: Our results may provide initial evidence that childhood OP/OC experiences would have negative effects on young people’s mental health which merits further investigations, especially in clinical populations.
- 16 October 2023
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 14, 1238254
Open AccessProfile and mental health characterization of childhood overprotection/overcontrol experiences among Chinese university students: a nationwide survey
Introduction: The childhood experiences of being overprotected and overcontrolled by family members have been suggested to be potentially traumatic. However, the possible associated factors of these experiences among young people are still not well studied. This study aimed to partly fill such gaps by a relatively large, nationwide survey of Chinese university students.Methods: A total of 5,823 university students across nine different provinces in China were included by the convenience sampling method in the data analyses. All participants completed the overprotection/overcontrol (OP/OC) subscale in a recently developed 33-item childhood trauma questionnaire (CTQ- 33). Data were also collected on all participants’ socio-demographic profiles and characterization of mental health. Binary logistic regression was conducted to investigate the associated socio-demographic and psychological factors of OP/ OC.Results: The prevalence of childhood OP/OC was estimated as 15.63% (910/5,823) based on a cutoff OP/OC subscale score of ≥ 13. Binary logistic regression suggested that being male, being a single child, having depression, having psychotic-like experiences, lower family functioning, and lower psychological resilience were independently associated with childhood OP/OC experiences (all corrected-p < 0.05). The OP/OC was also positively associated with all the other trauma subtypes (abuses and neglects) in the CTQ-33, while there are both shared and unique associated factors between the OP/OC and other trauma subtypes. Post-hoc analyses suggested that OP/OC experiences were associated with depression in only females and associated with anxiety in only males.Discussion: Our results may provide initial evidence that childhood OP/OC experiences would have negative effects on young people’s mental health which merits further investigations, especially in clinical populations.
- Open Access
- 1 October 2023
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 19, 2295-2308
Effects of Combined Therapy of Olanzapine and Samidorphan on Safety and Metabolic Parameters in Schizophrenia Patients: A Meta-Analysis
Purpose: This meta-analysis intended to evaluate the safety and metabolic effects of the combination of olanzapine (OLZ) and samidorphan (SAM) in the treatment of schizophrenia (SCZ) patients. Patients and Methods: We searched for the English and Chinese databases for randomized controlled trials (RCTs) on the OLZ combined with SAM for SCZ. The English databases included PubMed, Web of Science, EMbase, and Cochrane Library, however, Chinese databases included Chinese Biology Medicine (CBM), VIP, Wanfang, and China National Knowledge Infrastructure (CNKI). All database searches were due by May 31, 2023. Using Review Manager 5.4 software, a meta-analysis was conducted following a literature review and data extraction. Results: This study included five RCTs involving 1781 patients. Regarding safety, the meta-analysis revealed that the probability of weight gain was reduced in the OLZ and SAM group than in the OLZ group (RR = 0.83, 95% CI (0.69, 0.99), P < 0.05). Statistically, the incidence of severe adverse safety events, dry mouth, headache, drowsiness, death, and suicidal perception events was insignificant (P > 0.05); in terms of metabolism, compared with the OLZ group, the OLZ plus SAM group reduced total cholesterol (TC) levels (MD = − 3.58, 95% CI (− 6.81, − 0.34), P < 0.05). However, it had no significant effect on metabolic indices, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides, glucose, and insulin index (P > 0.05). Conclusion: In patients with SCZ, treatment with the combination of OLZ and SAM decreased the incidence of weight gain adverse events and TC levels; nevertheless, it did not affect other adverse events or metabolic parameters. These findings provide clinicians with evidence-based guidance and support for drug selection. However, it is crucial to confirm these findings through further high-quality research.
- 1 October 2023
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 19, 2295-2308
Open AccessEffects of Combined Therapy of Olanzapine and Samidorphan on Safety and Metabolic Parameters in Schizophrenia Patients: A Meta-Analysis
Purpose: This meta-analysis intended to evaluate the safety and metabolic effects of the combination of olanzapine (OLZ) and samidorphan (SAM) in the treatment of schizophrenia (SCZ) patients. Patients and Methods: We searched for the English and Chinese databases for randomized controlled trials (RCTs) on the OLZ combined with SAM for SCZ. The English databases included PubMed, Web of Science, EMbase, and Cochrane Library, however, Chinese databases included Chinese Biology Medicine (CBM), VIP, Wanfang, and China National Knowledge Infrastructure (CNKI). All database searches were due by May 31, 2023. Using Review Manager 5.4 software, a meta-analysis was conducted following a literature review and data extraction. Results: This study included five RCTs involving 1781 patients. Regarding safety, the meta-analysis revealed that the probability of weight gain was reduced in the OLZ and SAM group than in the OLZ group (RR = 0.83, 95% CI (0.69, 0.99), P < 0.05). Statistically, the incidence of severe adverse safety events, dry mouth, headache, drowsiness, death, and suicidal perception events was insignificant (P > 0.05); in terms of metabolism, compared with the OLZ group, the OLZ plus SAM group reduced total cholesterol (TC) levels (MD = − 3.58, 95% CI (− 6.81, − 0.34), P < 0.05). However, it had no significant effect on metabolic indices, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides, glucose, and insulin index (P > 0.05). Conclusion: In patients with SCZ, treatment with the combination of OLZ and SAM decreased the incidence of weight gain adverse events and TC levels; nevertheless, it did not affect other adverse events or metabolic parameters. These findings provide clinicians with evidence-based guidance and support for drug selection. However, it is crucial to confirm these findings through further high-quality research.